| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 198,330 | | Cost of Revenue | 157,913 | | | Gross Profit | 40,417 | | | Operating Expenses | | Research Development | 3,951 | | Selling General and Administrative | 4,285 | | Non Recurring |
-
| | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 32,181 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,841 | | Earnings Before Interest And Taxes | 35,022 | | Interest Expense | 26 | | Income Before Tax | 34,996 | | Income Tax Expense | 12,321 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 22,675 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 22,675 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $22,675 |
|
0.02% Nasdaq 
0.46%
Income Statement
